General Information of Drug Transporter (DT)
DT ID DTD0389 Transporter Info
Gene Name SLC4A9
Transporter Name Anion exchange protein 4
Gene ID
83697
UniProt ID
Q96Q91
Post-Translational Modification of This DT
Overview of SLC4A9 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation

  Asparagine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC4A9 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

576

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC4A9 Asparagine 576 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC4A9 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

600

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC4A9 Asparagine 600 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC4A9 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

14

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A9 Serine 14 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC4A9 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

15

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A9 Serine 15 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC4A9 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

162

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A9 Serine 162 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC4A9 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

201

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A9 Serine 201 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC4A9 [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

651

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A9 Serine 651 has the potential to affect its expression or activity.

  Threonine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC4A9 [7]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

650

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC4A9 Threonine 650 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: B3A4_HUMAN)
2 Proteome-wide analysis of temporal phosphorylation dynamics in lysophosphatidic acid-induced signaling. Proteomics. 2012 Dec;12(23-24):3485-98.
3 Radiosensitization of human leukemic HL-60 cells by ATR kinase inhibitor (VE-821): phosphoproteomic analysis. Int J Mol Sci. 2014 Jul 7;15(7):12007-26.
4 Time-resolved Phosphoproteome Analysis of Paradoxical RAF Activation Reveals Novel Targets of ERK. Mol Cell Proteomics. 2017 Apr;16(4):663-679.
5 Phosphoproteome Analysis Reveals Differential Mode of Action of Sorafenib in Wildtype and Mutated FLT3 Acute Myeloid Leukemia (AML) Cells. Mol Cell Proteomics. 2017 Jul;16(7):1365-1376.
6 Phosphoproteomics of Primary Cells Reveals Druggable Kinase Signatures in Ovarian Cancer. Cell Rep. 2017 Mar 28;18(13):3242-3256.
7 Quantitative global phosphoproteomics of human umbilical vein endothelial cells after activation of the Rap signaling pathway. Mol Biosyst. 2013 Apr 5;9(4):732-49.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.